2018-2023 Mitomycin C Market Research: Global Industry Analysis and Forecast

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Mitomycin C market for 2018-2023.

Mitomycin C market, Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).

In the last several years, Global market of Mitomycin C was experienced an upward trend rapidly, with an average growth rate of 4.76%. In 2016, Global Revenue of Mitomycin C is nearly 119.83 M USD; the actual production is about 17370 K Unit.

The global average price of Mitomycin C is in the increasing trend, from 6.30 USD/Unit in 2012 to 6.90 USD/Unit in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.

The classification of Mitomycin C includes 2 Mg, 10 Mg, 40 Mg, and others. The proportion of 2 Mg in 2016 is about 41.5%, and the proportion is in decreasing trend from 2012 to 2016.

Mitomycin C is widely used in Cancer Treatment, Ophthalmic Use, and other field. The most proportion of Mitomycin C is Cancer Treatment, and the proportion in 2016 is 69%. The trend of Cancer Treatment is decreasing.

Japan is the largest supplier of Mitomycin C, with a production market share nearly 26.5% in 2016. India is the second largest supplier of Mitomycin C Media, enjoying production market share nearly 25% in 2016.

North America is the largest consumption place, with a consumption market share nearly 36% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 32.6%.

Over the next five years, LPI(LP Information) projects that Mitomycin C will register a -2.3% CAGR in terms of revenue, reach US$ 100 million by 2023, from US$ 120 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Mitomycin C market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

2 Mg

10 Mg

40 Mg

Other

Segmentation by application:

Cancer Treatment

Ophthalmic Use

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Enquire Here & check discount for [email protected]:

https://www.reporthive.com/enquiry.php?id=1565680&req_type=disc

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

Kyowa-kirin

Intas Pharmaceuticals

Teva

Bristol-Myers Squibb

Aspen

Speciality European Pharma

Alkem Laboratories

Varifarma

APOGEPHA

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives:

· To study and analyze the global Mitomycin C consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

· To understand the structure of Mitomycin C market by identifying its various subsegments.

· Focuses on the key global Mitomycin C manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

· To analyze the Mitomycin C with respect to individual growth trends, future prospects, and their contribution to the total market.

· To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

· To project the consumption of Mitomycin C submarkets, with respect to key regions (along with their respective key countries).

· To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

· To strategically profile the key players and comprehensively analyze their growth strategies.

Read full Research Report [email protected]: https://www.reporthive.com/enquiry.php?id=1565680&req_type=purch

Table of Contents:

Chapter One: Scope of the Report

Chapter Two: Executive Summary

Chapter Three: Global Mitomycin C by Players

Chapter Four: Mitomycin C by Regions

Chapter Five: Americas

Chapter Six: APAC

Chapter Seven: Europe

Chapter Eight: Middle East & Africa

Chapter Nine: Market Drivers, Challenges and Trends

Chapter Ten: Marketing, Distributors and Customer

Read More…

List of Tables and Figures:

Figure Mitomycin C Consumed in Cancer Treatment

Figure Global Mitomycin C Market: Cancer Treatment (2013-2018) (K Units)

Figure Global Mitomycin C Market: Cancer Treatment (2013-2018) ($ Millions)

Figure Global Cancer Treatment YoY Growth ($ Millions)

Figure Mitomycin C Consumed in Ophthalmic Use

Figure Global Mitomycin C Market: Ophthalmic Use (2013-2018) (K Units)

Figure Global Mitomycin C Market: Ophthalmic Use (2013-2018) ($ Millions)

Figure Global Ophthalmic Use YoY Growth ($ Millions) and know more…



Source by Mike Ross

Leave a Reply

Your email address will not be published. Required fields are marked *